New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2014
09:12 EDTRBCN, HZNP, ORCL, RENN, PSUN, OWW, EXAS, KBHOn The Fly: Pre-market Movers
UP AFTER EARNINGS: KB Home (KBH), up 7%...Pacific Sunwear (PSUN), up 7%. ALSO HIGHER: Horizon Pharma (HZNP), up 23% after deal to acquire Ireland's Vidara Therapeutics through reverse merger... Exact Sciences (EXAS), up 6.5% after a clinical trial of its Cologuard test, which it co-developed with the Mayo Clinic, showed "unprecedented" rates of precancer and cancer detection by a noninvasive test... DOWN AFTER EARNINGS: Oracle (ORCL), down 3.3%... Renren (RENN), down 7%. ALSO LOWER: Orbitz (OWW), down 5.4% after Goldman downgraded shares to Sell from Neutral... Rubicon (RBCN), down 6% after 2.5M share spot secondary offering priced at $13.00.
News For OWW;ORCL;KBH;PSUN;HZNP;EXAS;RENN;RBCN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 26, 2014
12:51 EDTRBCNAsian sapphire supplier stocks driven higher by Apple rumors, AppleInsider says
Subscribe for More Information
November 25, 2014
12:45 EDTEXASExact Sciences says CMS issues final payment decision regarding Cologuard
Exact Sciences announced that the Centers for Medicare & Medicaid Services,CMS, has issued its final payment decision regarding Cologuard and will reimburse it at $502 per test. Cologuard is the first and only FDA-approved noninvasive stool DNA colorectal cancer screening test. The final payment decision follows a comprehensive evaluation by the agency as part of a joint FDA and CMS parallel review pilot program. Cologuard is the first technology to gain approval through this program. “CMS’ final payment decision represents a major milestone by providing 50M Medicare patients access to this noninvasive colorectal cancer screening option,” said Kevin Conroy, president, CEO and chairman of Exact Sciences. “We thank FDA and CMS for giving Exact Sciences the opportunity to bring this new screening option to patients and physicians.”
November 24, 2014
09:10 EDTOWWOrbitz coverage assumed with a Neutral at Credit Suisse
Subscribe for More Information
08:34 EDTORCLJefferies software analysts hold an analyst/industry conference call
Subscribe for More Information
November 21, 2014
10:47 EDTOWWAmazon reported travel entry viewed positively by Piper's Munster
Subscribe for More Information
10:00 EDTKBHOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Best Buy (BBY) upgraded to Outperform from Market Perform at Telsey Advisory... BlackRock (BLK) upgraded to Outperform from Market Perform at Bernstein... Cerner (CERN) upgraded to Outperform from Market Perform at Cowen... Community Health (CYH) upgraded to Outperform from Market Perform at Raymond James... Lockheed Martin (LMT) upgraded to Neutral from Sell at UBS... Teekay Offshore Partners (TOO) upgraded to Buy from Neutral at Citigroup... Trinity Industries (TRN) upgraded to Buy from Neutral at Longbow... Zebra Technologies (ZBRA) upgraded to Overweight from Neutral at JPMorgan... Ross Stores (ROST) upgraded to Hold from Sell at Maxim... St. Jude Medical (STJ) upgraded to Outperform from Market Perform at Cowen... Wolverine World Wide (WWW) upgraded to Buy from Neutral at DA Davidson... D.R. Horton (DHI) upgraded to Market Perform from Underperform at Raymond James... KB Home (KBH) upgraded to Market Perform from Underperform at Raymond James... Sony (SNE) upgraded to Overweight from Neutral at JPMorgan.
08:17 EDTKBHKB Home upgraded to Market Perform from Underperform at Raymond James
Subscribe for More Information
November 20, 2014
17:40 EDTRENNRenren sees Q4 revenue down 44.6%-51.1% YoY to $15M-$17M
17:38 EDTRENNRenren reports Q3 revenue $21.6M, consensus $22.76M
Subscribe for More Information
16:53 EDTORCLOracle initiated with a Hold at Jefferies
Target $41.
07:24 EDTEXASGoldman to hold a conference
Subscribe for More Information
07:11 EDTORCLBofA/Merrill to hold a conference
Subscribe for More Information
November 18, 2014
16:12 EDTHZNPHorizon Pharma reports positive effect of RAYOS in reducing joint stiffness
Subscribe for More Information
14:01 EDTPSUNPacific Sunwear names Amber Fredman-Tarshis as Chief Marketing Officer
Pacific Sunwear of California announced the appointment of Amber Fredman-Tarshis as its Senior Vice President and Chief Marketing Officer.
November 14, 2014
08:06 EDTHZNPHorizon Pharma 11.66M share Secondary priced at $12.05
Subscribe for More Information
06:12 EDTORCLSAP to pay Oracle $359M to settle legal battle, WSJ reports
Subscribe for More Information
November 13, 2014
14:56 EDTHZNPHorizon Pharma says Watson Labs filed ANDA for generic PENNSAID
Subscribe for More Information
07:18 EDTKBHUBS to hold a conference
Building & Building Products Annual CEO Conference is being held in New York on November 13 with webcasted company presentations to begin at 9:30 am; not all company presentations may be webcasted. Webcast Link
07:12 EDTORCLOracle to hold a meeting
2014 OAGi Plenary Meeting is being held in Redwood City, California on November 13-14.
07:06 EDTHZNPHorizon Pharma files to sell 11.66M shares for existing holders
Horizon Pharma announced a proposed underwritten secondary offering of 11.66M of its ordinary shares held by certain of its existing shareholders. Morgan Stanley, Citigroup, Cowen and Jefferies are acting as joint book-running managers for this offering. JMP Securities is acting as financial advisor for this offering.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use